Cellpelletswerethawedonice,resUSPendedin: AtypicalassayforestablishtheapparentVmaxandKmoftheSubstrateANDROST-4-ENE-3,17-DIONEofthenormal&mutantHSD17B3enzymeused: AtypicalassaytoestablishtheapparentpHofthenormal&mutantHSD17B3enzymeused: TransfectionofDNAinto293TcellsbyusingLIPOFECTAMINEPLUSReagentpackage(LIFETECHNOLOGIESCat.No.10964-013):Protocol*10mMTris-HCl(pH7.4)/150mMKCL/1mMEDTA/2mMDithiothreitol(DTT)atproteinconcentrationof3-6mg/ml,andsnap-frozenondryice.Afterthawingat37°C,theextractswerechilledoniceandsonicatedfor30sec.
*20-30microgramoftotalproteinin0.2mLof100mMTris-citrate(pH6)/2mMDTT.
*Steroidsubstratewasaddedindifferentconcent.(0.1-8microM),andNADPHwasaddedtoafinalcocent.of2mM.
*Reactionswereinitiatedbytheadditionofenzymeandwerecarriedoutfor25’-30’minat37°C.
*SerialvariationofpH(range4.5pH-8.5pH),forthereactionBuffer:100mMTris-citrate/2mMDTT.
*Steroidsubstratewasaddedatfinalconcent.of5mM(where1mMwere14C-ANDROST-4-ENE-3,17-DIONEand4mMwerecoldsubstrate).
*Thedaybeforetransfection,splitandplatingthecells,sothethattheyare50%-60%confluentthedayoftransfection.Avoidantibioticsatthetimeoftransfectionandduring.
*Culturevessel:100mm
*plasmidDNA;4microg*plasmidb-gal;1microg
*PLUSreagent;20microliter
*LIPOFECTAMINEPLUSReagent;30microliter
*Incubateat37°Cat5%CO2for3h(seeLIFETECHNOLOGIESprotocol.)
*After3hinc.,increasevolumeofmediumtonormalvolume(seeLIFETECHNOLOGIESprotocol.)
*Thecellextractwereassayedforreportergeneactivity48hafterthestartoftransfection.
相关产品: